Survival benefit for patients with colorectal cancer detected by population-based screening program using an immunochemical fecal occult blood test

International Journal of Oncology

Volumn 9, Issue 4, 1996, Pages 685-691

  Wada, Toyohito ^a   Saito, Hiroshi ^a   Soma, Yasushi ^a   Koeda, Junichi ^a   Kawaguchi, Hitoshi ^a   Tanaka, Masanori ^a   Yoshida, Yutaka ^a   Munakata, Akihiro ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

colorectal cancer screening; fecal occult blood test; immunochemical hemagglutination test; proportional hazard model; survival analysis

Indexed keywords

ADULT; AGED; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; OCCULT BLOOD; PRIORITY JOURNAL; SURVIVAL;

EID: 0029844035     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.9.4.685     Document Type: Article

References (21)

1. Tominaga S, Aoki K, Fujimoto I and Kurihara M: Cancer mortality and morbidity statistics. Japan and the World-1994. Japan Scientific Societies Press, Tokyo, 1995.
2. Winawer SJ, Schottenfeld D and Flehinger BJ: Colorectal cancer screening. J Natl Cancer Inst 83: 243-253, 1991.
3. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM and Ederer F: Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 328: 1365-1371, 1993.
4. Selby JV, Friedman GD, Quesenberry CP and Weiss NS: Effect of fecal occult blood testing on mortality from colorectal cancer: a case control study. Ann Intern Med 118: 1-6, 1993.
5. Saito H and Yoshida Y: Mass screening: Japanese perspective. In: Prevention and Early Detection of Colorectal Cancer. Young GP, Levin B and Rozen P (eds). WB Saunders, London, pp301-311, 1996.
6. Saito H, Tsuchida S, Kakizaki R, Fukushi M, Sano M, Aisawa T, Munakata A and Yoshida Y: An immunological fecal occult blood test for mass screening of colorectal cancer by reversed passive hemagglutination (RPHA). Jpn J Gastroenterol 81: 2831, 1984. (rapid communication).
7. Thomas WM, Hardcatsle JD, Jackson J and Pye G: Chemical and immunological testing for faecal occult blood: a comparison of two tests in symptomatic patients. Br J Cancer 65: 618-620, 1992.
8. St John DJB, Young GP, Alexeyeff MA, Deacon MC, Cuthbertson AM, Macrae FA and Penfold JCB: Evaluation of new occult blood tests for detection of colorectal neoplasia. Gastroenterology 104: 1661-1668, 1993.
9. Robinson MHE, Marks CG, Farrands PA, Thomas WM and Hardcastle JD: Population screening for colorectal cancer: comparison between guaiac and immunological feacal occult blood tests. Br J Surg 81: 448-451, 1994.
10. Allison JE, Tekawa IS, Ransom LJ and Adrain AL: A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med 334: 155-159, 1996.
11. Saito H, Soma Y, Koeda J, Wada T, Kawaguchi H, Sobue T, Aisawa T and Yoshida Y: Reduction in risk of mortality from colorectal cancer by fecal occult blood screening with immunochemical hemagglutination test: a case-control study. Int J Cancer 51: 465-469, 1995.
12. Watanabe H: Case presentation of early colorectal carcinoma and its pathological diagnosis by leading pathologists. Stomach and Intestine 27: 633-671, 1992.
13. Gabriel WB, Dukes C and Bussey HJR: Lymphatic spread in cancer of the rectum. Br J Surg 23: 395-413, 1936.
14. Fisher ER, Sass R, Palekar A, Fisher B and Wolmark N: Dukes' classification revisited. Finding from National Surgical Adjuvant Breast and Bowel Projects (protocol R-01). Cancer 64: 2354-2360, 1989.
15. Kaplan EL and Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958.
16. Peto R, Pike MC and Armitage P: Design and analysis of randomized clinical trials requiring prolonged observation. Br J Cancer 35: 1-39, 1977.
17. Cox DR: Regression models and life-table. J Roy Stat Soc 34: 187-220, 1972.
18. SAS Institute Inc: A procedure for Cox's proportional hazards regression analysis. SAS Inc, Cary, North Carolina, 1991.
19. Thomas WM and Hardcastle JD: An update on the Nottingham trial of faecal occult blood screening for colorectal carcinoma. In: Cancer Screening. Miller AB, Chamberlain J, Day NE, Hakama M and Prorok PC (eds). Cambridge University Press, Cambridge, pp 106-115, 1990.
20. Yasutomi M, Koyama Y and Kotake K: Multi-institutional registry of large-bowel cancer, (9th ed.). Japanese Research Society for Colorectal Cancer of the Colon and Rectum. Osaka, 1994.
21. Kodaira S, Yao T, Nakamura K, Watanabe H, Maruyama M, Ushio K, Shimoda T and Iwashita M: Submucosal invasive carcinoma of the colon and rectum with metastasis. Stomach and Intestine 29: 1137-1142, 1994.